Table 1 Baseline clinical characteristics of participants in our study
From: Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
| Â | CAP372 | CAP212 | Pvalue |
|---|---|---|---|
N | 372 | 212 | - |
Men | 54% | 52% | 0.62 |
Smoker (%) | 0% | 36% | 2.2 × 10-6 |
Age (years) | 54.9 ± 12.6 | 53.7 ± 12.6 | 0.29 |
BMI (kg/m2) | 27.7 ± 5.3 | 27.7 ± 5.3 | 0.89 |
LDLC level (mg/dl) | 132 ± 28 | 134 ± 37 | 0.38 |
LDLC level change after statin treatment (mg/dl) | -56.7 ± 19.8 | -55.7 ± 23.8 | 0.61 |